Guru Ownership Trend
Guru Analysis for ADMA Biologics, Inc. (ADMA)
ADMA Biologics, Inc. (ADMA), a key player in the Healthcare sector, continues to attract institutional attention.
As of Q4 2025, a total of 9 Super Investors (Gurus) hold positions in the company, with a combined stake valued at approximately $94.93 M.
Top institutional holders include Terry Smith and Renaissance Technologies.
Institutional sentiment is currently Bullish. This is evidenced by a $12.12 M net inflow during the quarter.
Recent activity highlights Ray Dalio who increased their stake by 209.3%. Conversely, Steven Cohen reduced exposure by 70.2%.
Key Holders
Top 5 by Value
Top 5 by Conviction
Recent Activity Breakdown (Q4 2025)
Guru Consensus (Q4 2025)
FAQs for ADMA Biologics, Inc. (ADMA)
Major holders include Terry Smith ($38.34 M), Renaissance Technologies ($27.96 M), Chuck Royce ($22.52 M). According to the latest reported data, 9 tracked investment managers collectively hold approximately 6.1 M shares.
According to the latest 13F reporting period, sentiment appears Bullish (Net Buying). There was a net inflow of $12.12 M, with 7 managers increasing positions and 2 managers reducing holdings.
During the most recent reporting period, 2 managers trimmed their positions, while 0 fully exited ADMA. The total reported sell value was $39.51 M.
Yes, 2 managers opened new positions in ADMA, and 5 increased their existing holdings. The total reported buy value was $51.62 M.
